Enhancement of arsenic trioxide-mediated apoptosis using docosahexaenoic acid in arsenic trioxide-resistant solid tumor cells

International Journal of Cancer. Journal International Du Cancer
Melanie BaumgartnerThomas Bachleitner-Hofmann

Abstract

It has been shown that the polyunsaturated fatty acid docosahexaenoic acid (DHA) can sensitize various tumor cells to reactive oxygen species (ROS)-inducing anticancer agents. Recently, we demonstrated that DHA also enhances the apoptotic effect of clinically achievable concentrations (1-2 microM) of arsenic trioxide (As2O3) in several As2O3-resistant human leukemic cell lines via a ROS-dependent mechanism. The aim of the present study was to evaluate whether this combined effect of As2O3 and DHA is also applicable to As2O3-resistant solid tumor cells. We have tested 12 different tumor cell lines, including MDA-MB-468, SK-BR-3, MCF-7 (breast cancer), ES-2, SKOV-3 (ovarian cancer), HT-29, SW-620, LS-174T (colon cancer), PC-3 (prostate cancer), HeLa (cervical cancer), PANC-1 (pancreatic cancer) and one primary melanoma cell line. With the exception of MDA-MB-468 and ES-2, all cells were resistant to treatment with either As2O3 or DHA alone. However, combined treatment with As2O3 and DHA significantly reduced viability in 7 of the 10 As2O3-resistant solid tumors tested. The cytotoxic effect of As2O3 and DHA was associated with the induction of apoptosis and a concomitant increase of intracellular lipid peroxidation products. Impor...Continue Reading

Citations

May 23, 2012·Cancer Chemotherapy and Pharmacology·Nawale HajjajiPhilippe Bougnoux
Jan 9, 2009·Apoptosis : an International Journal on Programmed Cell Death·Simona SeriniGabriella Calviello
Sep 26, 2013·Breast Cancer Research and Treatment·Md Mizanur RahmanGabriel Fernandes
Jun 14, 2013·BioMed Research International·Nicolò MerendinoFrancesca Velotti
Mar 29, 2014·Nutrition Reviews·Simona SeriniGabriella Calviello
Aug 2, 2012·Cancer Treatment Reviews·Nawale Hajjaji, Philippe Bougnoux
Jan 4, 2012·Pancreatology : Official Journal of the International Association of Pancreatology (IAP) ... [et Al.]·Kyoung-Sub SongKyu Lim
Jul 9, 2008·Experimental and Toxicologic Pathology : Official Journal of the Gesellschaft Für Toxikologische Pathologie·Xishan WangBaofeng Yang
Jul 11, 2006·Cancer Science·Bing LiuXueying Sun
Jan 4, 2008·Journal of Cellular Biochemistry·Andy T Y LauJen-Fu Chiu
Oct 12, 2005·International Journal of Cancer. Journal International Du Cancer·Liqiong LuoXueying Sun
Aug 30, 2008·Molecular Nutrition & Food Research·Paraskevi ZaganaSophia G Antimisiaris
Mar 20, 2013·BioMed Research International·Li ShenJunbo Ge
Jan 16, 2009·Journal of Ovarian Research·C William Helm, J Christopher States
Dec 27, 2013·Oxidative Medicine and Cellular Longevity·Omotayo O ErejuwaMohd S Ab Wahab
Dec 20, 2008·Journal of Korean Neurosurgical Society·Dae Won KimTae Young Kim
Feb 6, 2017·Drug Delivery·Rajshree L Shinde, Padma V Devarajan
Sep 14, 2012·The Journal of International Medical Research·X P SunX Sun
Jan 13, 2011·JPEN. Journal of Parenteral and Enteral Nutrition·Hongyu XueVickie E Baracos
Jul 28, 2019·Journal of Lipid Research·Hidetoshi YamadaTetsuro Yamashita
Dec 21, 2017·International Journal of Molecular Sciences·Paola Antonia CorsettoChiara Riganti
Aug 8, 2006·Molecular Cancer Therapeutics·Wei-Qun DingStuart E Lind
Sep 29, 2019·Clinical Nutrition : Official Journal of the European Society of Parenteral and Enteral Nutrition·Esmaeil MortazJohan Garssen
Feb 5, 2021·Signal Transduction and Targeted Therapy·Hong-Fa YanPeng Lei

❮ Previous
Next ❯

Related Concepts

Related Feeds

Apoptosis in Cancer

Apoptosis is an important mechanism in cancer. By evading apoptosis, tumors can continue to grow without regulation and metastasize systemically. Many therapies are evaluating the use of pro-apoptotic activation to eliminate cancer growth. Here is the latest research on apoptosis in cancer.

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis